Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Sorrentino, Atenulf
DOB: 29-AUG-1965 (Age: 60)
Gender: male
ID: 5852-163953-2 (ECI)
Author
Caffarelli, Carlo
Patient summary Document
European Patient Summary
Report Date: 29-JUN-2025

Problem list

Condition Onset Date / Period Status
Proteinuria due to type 2 diabetes mellitus 30-Jun-2013 active
Microalbuminuria due to type 2 diabetes mellitus 17-Oct-2004 active
Metabolic syndrome X 29-Feb-2004 active
Disorder of kidney due to diabetes mellitus 23-Feb-2003 active
Essential hypertension 06-Feb-2000 active
Sinusitis 07-Jan-2024 - 15-Feb-2024 inactive
Chronic kidney disease stage 4 04-Nov-2018 - 25-Aug-2021 inactive
Chronic kidney disease stage 3 30-Jun-2013 - 25-Aug-2021 inactive
Chronic kidney disease stage 2 17-Oct-2004 - 25-Aug-2021 inactive
Chronic kidney disease stage 1 23-Feb-2003 - 25-Aug-2021 inactive

Medication list

Medication Since Form Dosage Reason
Human isophane insulin 70 unit/mL and recombinant human regular insulin 30 unit/mL solution for injection 2025-06-29 - Inject 10 units (70/30 insulin) subcutaneously twice daily before breakfast and dinner Prediabetes
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-06-29 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-06-29 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Tacrolimus 1 mg prolonged-release oral tablet 2025-06-29 - 1 tablet (1 mg) once daily History of renal transplant (situation)

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 29-Jun-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 18-Jun-2023
SARS-CoV-2 mRNA vaccine 02-May-2021

Procedure History list

Procedure Date Reason
Medication reconciliation 24-Dec-2023 -
Assessment of health and social care needs 24-Dec-2023 -
Transplantation of kidney regime 27-Aug-2021 History of renal transplant (situation)
Transplant of kidney 24-Aug-2021 Awaiting transplantation of kidney (situation)
Pretransplant evaluation of kidney recipient 24-Aug-2021 Awaiting transplantation of kidney (situation)
Depression screening 03-Dec-2017 -
Screening for substance abuse 03-Dec-2017 -
Screening for domestic abuse 03-Dec-2017 -
Assessment of substance use 03-Dec-2017 -

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Care plan 25-Aug-2021 -
Dialysis care plan 31-May-2018 -
Diabetes self management plan 29-Feb-2004 Prediabetes (finding)
  • Achieve and maintain HbA1c within individualized target range to reduce risk of diabetes complications.
  • Maintain blood pressure within recommended range for patients with diabetes and kidney disease.
  • Reduce urinary albumin excretion to slow progression of diabetic kidney disease.
  • Achieve and maintain healthy weight to improve metabolic control and reduce cardiovascular risk.
  • Engage in regular physical activity as recommended for diabetes self-management.
Lifestyle education regarding hypertension 06-Feb-2000 Essential hypertension (disorder)
  • Patient will receive education on lifestyle changes (diet, exercise, sodium reduction, weight management, alcohol moderation) to help control blood pressure.
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-06-29 2024-06-23
Body Height 175 cm 175 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} 1 {score}
Body Weight 85.8 kg 85.8 kg
Body mass index (BMI) [Ratio] 28 kg/m2 28 kg/m2
Heart rate 84 /min 86 /min
Respiratory rate 15 /min 14 /min
Blood pressure panel with all children optional 87 mm[Hg] 89 mm[Hg]

Relevant diagnostic tests/laboratory data

Recent Lab Observations 29-JUN-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 3.3 L 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 87.5 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.1 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.1 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.1 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.3 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.8 22 - 29 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 29-Feb-2004